EVAg

Viral DNAextracted from a Monkeypox infected Vero cell culture supernatants

Infectious cell culture supernatant of Measles virus D8. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of human Coxsackievirus B4. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of human Coxsackievirus B4. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of Measles virus D8. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of Measles virus D8. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of Measles virus D8. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of Measles virus D8. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of Echovirus 11. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of human Coxsackievirus B5. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of human Coxsackievirus A6. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of human Enterovirus A71. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of human Enterovirus A71. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of human Coxsackievirus A10. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of human Coxsackievirus B5. This strain is preserved in viral storage medium -80°C.

Infectious cell culture supernatant of human Coxsackievirus A6. This strain is preserved in viral storage medium -80°C.

Course instruction will be conducted in the high containment facility at ACDP, Geelong, Victoria, Australia. Participants will receive a 5-day intensive course that includes interactive theoretical and practical experiences. Topics addressed will include introduction to BSL4 suited laboratories, regulatory frameworks, operational oversight, engineering controls and maintenance considerations.

An in-depth theoretical and practical application of biosafety, biocontainment and biosecurity under the Australia/New Zealand standards and Australian regulatory framework for Biosecurity Containment and Physical Containment level 3 and 4 laboratory and animal facilities.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence of the NP region from Crimean congo hemorrhagic fever virus and can be used as positive control for extraction and real time RT-PCR usinf specific Primers and probe ref: 001K-05698. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence of the L region from Crimean congo hemorrhagic fever virus and can be used as positive control for extraction and real time RT-PCR using specific Primers and probe ref: 001K-05699 Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence of the G2 protein and S segment from Rift Valley Fever virus and can be used as positive control for extraction and real time RT-PCR using specific Primers and probe (ref:001K-05697) . Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence in the segment S region from Oropouche virus and can be used as positive control for extraction and real time RT-PCR using specific Primers and probe ref:001K-06040 . Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence of Nucleocapsid in the segment S from Toscana virus and can be used as positive control for extraction and real time RT-PCR using specific Primers and probe ref: 001K-06008. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence of the NS5 region from Usutu virus and can be used as positive control for extraction and real time RT-PCR using specific Primers and probe ref: 001K-06005. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence of the NS3 and 3'UTR region from Tick borne encephalitis virus and can be used as positive control for extraction and real time RT-PCR using specific Primers and probe. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.